Liquid biopsy:Precise diagnosis and therapy for cholangiocarcinoma 被引量：1

下载PDF

导出

摘要 The following letter to the editor highlights the review titled“Liquid biopsy in cholangiocarcinoma:Current status and future perspective”in World J Gastrointest Oncol 2021;13:332-350.It is necessary to realize individualized therapy to improve the clinical prognosis of patients with cholangiocarcinoma.

作者 Si-Qin Wang Chu-Xing Chai Bi-Rong Wang Feng Zhu Dan Shang Min Li

机构地区 Department of Vascular Surgery Department of Hepatobiliary Surgery Department of Breast and Thyroid Surgery

出处《World Journal of Gastrointestinal Oncology》 SCIE 2022年第1期362-365,共4页 世界胃肠肿瘤学杂志（英文版）（电子版）

基金 Wuhan Municipal Health Commission,No.WX14B22 National Natural Science Foundation of China,No.81874208 and No.81700425.

关键词 Liquid biopsy CHOLANGIOCARCINOMA Diagnosis THERAPY Precision medicine

分类号 R735.8 [医药卫生—肿瘤]

引文网络
相关文献

参考文献1

1Gianluca Rompianesi,Marcello Di Martino,Alex Gordon-Weeks,Roberto Montalti,Roberto Troisi.Liquid biopsy in cholangiocarcinoma:Current status and future perspectives[J].World Journal of Gastrointestinal Oncology,2021,13(5):332-350. 被引量：5

二级参考文献8

1Yasuni Nakanuma,Yasunori Sato,Kenichi Harada,Mokoto Sasaski,Hiroko Ikeda.Pathological classification of intrahepatic cholangiocarcinoma based on a new concept[J].World Journal of Hepatology,2010,2(12):419-427. 被引量：38
2Endobiliary brush cytology during percutaneous transhepatic cholangiodrainage in patients with obstructive jaundice[J].Hepatobiliary & Pancreatic Diseases International,2005,4(1):98-103. 被引量：15
3Xiao-Hua Ye,Jia-Ping Huai,Jin Ding,Yan-Ping Chen,Xue-Cheng Sun.Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma:A meta-analysis[J].World Journal of Gastroenterology,2013,19(46):8780-8788. 被引量：2
4Chia-Cheng Lin,Ping-Yi Lin,Yao-Li Chen.Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis:Clinical implications[J].World Journal of Gastroenterology,2013,19(3):375-380. 被引量：16
5Murad Aljiffry,Mark J Walsh,Michele Molinari.Advances in diagnosis,treatment and palliation of cholangiocarcinoma:1990-2009[J].World Journal of Gastroenterology,2009,15(34):4240-4262. 被引量：83
6Hyo Jung Kim,Jae Seon Kim,Moon Kyung Joo,Beom Jae Lee,Ji Hoon Kim,Jong Eun Yeon,Jong-Jae Park,Kwan Soo Byun,Young-Tae Bak.Hepatolithiasis and intrahepatic cholangiocarcinoma: A review[J].World Journal of Gastroenterology,2015,21(48):13418-13431. 被引量：75
7Hye Sook Han,Mi Jin Kim,Joung-Ho Han,Jieun Yun,Hee Kyung Kim,Yaewon Yang,Ki Bae Kim,Seon Mee Park.Bile-derived circulating extracellular mi R-30d-5p and mi R-92a-3p as potential biomarkers for cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2020,19(1):41-50. 被引量：9
8Simone Brivio,Massimiliano Cadamuro,Mario Strazzabosco,Luca Fabris.Tumor reactive stroma in cholangiocarcinoma:The fuel behind cancer aggressiveness[J].World Journal of Hepatology,2017,9(9):455-468. 被引量：3

共引文献4

1Hussein H Khachfe.Use of liquid biopsies in gastrointestinal cancers[J].World Journal of Gastrointestinal Oncology,2021,13(9):1210-1212.
2Gianluca Rompianesi,Francesca Pegoraro,Carlo DL Ceresa,Roberto Montalti,Roberto Ivan Troisi.Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases[J].World Journal of Gastroenterology,2022,28(1):108-122. 被引量：9
3Mukul Vij,Yogesh Puri,Ashwin Rammohan,Gowripriya G,Rajesh Rajalingam,Ilankumaran Kaliamoorthy,Mohamed Rela.Pathological,molecular,and clinical characteristics of cholangiocarcinoma:A comprehensive review[J].World Journal of Gastrointestinal Oncology,2022,14(3):607-627. 被引量：7
4Lavinia-Patricia Mocan,Maria Ilieș,Carmen Stanca Melincovici,Mihaela Spârchez,RareșCrăciun,Iuliana Nenu,Adelina Horhat,Cristian Tefas,Zeno Spârchez,Cristina Adela Iuga,Tudor Mocan,Carmen Mihaela Mihu.Novel approaches in search for biomarkers of cholangiocarcinoma[J].World Journal of Gastroenterology,2022,28(15):1508-1525. 被引量：1

同被引文献9

1Kanuengnuch Kosriwong,Trevelyan R Menheniott,Andrew S Giraud,Patcharee Jearanaikoon,Banchob Sripa,Temduang Limpaiboon.Trefoil factors:Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma[J].World Journal of Gastroenterology,2011,17(12):1631-1641. 被引量：16
2李航宇,李岩,刘丹,孙宏治,刘金钢.LPS通过p38/MAPK调控胆管癌细胞系ICBD的上皮间质转化[J].世界华人消化杂志,2013,21(21):2070-2075. 被引量：5
3Haixia Li,Jinghui Liang,Jiang Wang,Jingyi Han,Shuang Li,Kai Huang,Chuanyong Liu.Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p[J].Cancer Communications,2021,41(6):472-491. 被引量：8
4杨济萌,陆录,钦伦秀.肝内胆管癌分子靶向治疗研究现状[J].肿瘤综合治疗电子杂志,2021,7(3):12-16. 被引量：1
5苗辉.血清外泌体癌胚抗原检测作为肝癌和胆管癌诊断指标的临床应用[J].医学理论与实践,2021,34(17):3066-3068. 被引量：2
6李剑明,冯对平.胆汁中生物标志物检测对胆管癌诊断价值的研究进展[J].现代肿瘤医学,2021,29(19):3487-3490. 被引量：1
7高龙,吴越,闫海丽,丰继平,杜江锋,冯对平.肝内胆管癌的局部治疗现状与研究进展[J].中华放射学杂志,2021,55(10):1103-1107. 被引量：2
8Renato Patrone,Francesco Izzo,Raffaele Palaia,Vincenza Granata,Guglielmo Nasti,Alessandro Ottaiano,Gilda Pasta,Andrea Belli.Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma:A systematic review[J].World Journal of Gastrointestinal Oncology,2021,13(12):2203-2215. 被引量：3
9Ye-Rong Qian,Na Jiang,Peng Liu,Xu-Feng Zhang,Xue-Min Liu,Yi Lv,Jun-Xi Xiang.Hepatocellular-cholangiocarcinoma with sarcomatous change:Clinicopathological features and outcomes[J].Hepatobiliary & Pancreatic Diseases International,2021,20(6):574-578. 被引量：1

引证文献1

1王俊,李建刚,李亮.MAPK13调控胆管癌细胞增殖、侵袭和上皮间质转化进程的机制研究[J].肝胆胰外科杂志,2022,34(6):349-356. 被引量：1

二级引证文献1

1倪家慧,钟日升,王雄文,周恒立,刘昌华,田雯,潘华峰.健脾化瘀法防治慢性萎缩性胃炎“炎-癌”转化的系统评价及网络药理学研究[J].中药新药与临床药理,2023,34(7):997-1009. 被引量：1

1Peng Cai,Yichao Wu,Marc Redmile-Gordon.Response to Letter to the Editor-“Soil biofilms”:Misleading description of the spatial distribution of microbial biomass in soils[J].Soil Ecology Letters,2020,2(1):6-7.
2Yu-Xi Cheng,Wei Tao,Wei Zhang,Dong Peng.Letter to editor‘Gastroenteropathy in gastric cancer patients concurrent with diabetes mellitus’[J].World Journal of Diabetes,2021,12(11):1967-1968. 被引量：1
3FRONTIERS OF MEDICINE Vol.152021 TOTAL CONTENTS[J].Frontiers of Medicine,2021,15(6).
4Hossein Haghbin,Muhammad Aziz.Artificial intelligence and cholangiocarcinoma:Updates and prospects[J].World Journal of Clinical Oncology,2022,13(2):125-134. 被引量：2
5Jie Li,Mengyue Xu,Junya Peng,Jingqiao Wang,Yupei Zhao,Wenming Wu,Xun Lan.Novel technologies in cfDNA analysis and potential utility in clinic[J].Chinese Journal of Cancer Research,2021,33(6):708-718. 被引量：3
6HUANG Shan-qing,LI Lu,WANG Zhan-zhang,XIAO Tao,LI Xiao-lin,LIU Shu-jing,ZHANG Ming,LU Hao-yang,WEN Yu-guan,SHANG De-wei.Modeling and simulation for individualized therapy of amisulpride in Chinese patients with schizophrenia:focus on inter interindi⁃vidual variability,therapeutic reference range and laboratory alert level[J].中国药理学与毒理学杂志,2021,35(9):661-662. 被引量：4
7World Federation of Chinese Medicine Societies Center for Translation[J].World Journal of Integrated Traditional and Western Medicine,2021,7(4).
8World Federation of Chinese Medicine Societies Center for Translation[J].World Journal of Integrated Traditional and Western Medicine,2021,7(6).
9Patrick Twohig,Thoetchai Bee Peeraphatdit,Sandeep Mukherjee.Current status of liver transplantation for cholangiocarcinoma[J].World Journal of Gastrointestinal Surgery,2022,14(1):1-11. 被引量：2
10王静,孙紫雲,郭苹,张龙妹.改进YOLOv5的白细胞检测算法[J].计算机工程与应用,2022,58(4):134-142. 被引量：31

World Journal of Gastrointestinal Oncology

2022年第1期

浏览历史

内容加载中请稍等...